LHCCX Holdings — Lord Abbett Health Care Fund
All 64 reported holdings of Lord Abbett Health Care Fund (LHCCX) by percentage of net assets, from the fund's latest SEC N-PORT filing.
| Holding | % of net assets | Value (USD) |
|---|---|---|
| Eli Lilly & Co | 8.89% | $724.32K |
| AstraZeneca PLC | 4.73% | $384.95K |
| Gilead Sciences Inc | 4.25% | $346.33K |
| Johnson & Johnson | 3.19% | $259.50K |
| Nektar Therapeutics | 3.17% | $258.35K |
| Natera Inc | 2.91% | $237.29K |
| Tarsus Pharmaceuticals Inc | 2.83% | $230.40K |
| Guardant Health Inc | 2.63% | $214.13K |
| Argenx SE | 2.49% | $203.11K |
| Novartis AG | 2.46% | $200.40K |
| CVS Health Corp | 2.37% | $193.23K |
| Madrigal Pharmaceuticals Inc | 2.22% | $181.09K |
| Intuitive Surgical Inc | 2.21% | $179.84K |
| Cogent Biosciences Inc | 2.19% | $178.34K |
| Galderma Group AG | 2.11% | $171.61K |
| UnitedHealth Group Inc | 2.10% | $170.79K |
| Celcuity Inc | 2.01% | $163.70K |
| Bridgebio Pharma Inc | 1.99% | $161.99K |
| Cencora Inc | 1.99% | $161.71K |
| Ascendis Pharma A/S | 1.97% | $160.11K |
| Abivax SA | 1.87% | $152.12K |
| Edwards Lifesciences Corp | 1.82% | $148.21K |
| Fixed Income Clearing Corp. | 1.78% | $144.82K |
| Mirum Pharmaceuticals Inc | 1.75% | $142.75K |
| Ucb SA | 1.75% | $142.14K |
| Fidelity Investments | 1.72% | $139.93K |
| Dianthus Therapeutics Inc | 1.70% | $138.28K |
| United Therapeutics Corp | 1.64% | $133.70K |
| Vertex Pharmaceuticals Inc | 1.63% | $132.92K |
| Thermo Fisher Scientific Inc | 1.48% | $120.70K |
| Revolution Medicines Inc | 1.35% | $110.11K |
| Teva Pharmaceutical Industries Ltd | 1.27% | $103.70K |
| Adaptive Biotechnologies Corp | 1.17% | $95.44K |
| PTC Therapeutics Inc | 1.12% | $91.15K |
| Insmed Inc | 1.05% | $85.89K |
| Mineralys Therapeutics Inc | 1.05% | $85.81K |
| Otsuka Holdings Co Ltd | 1.04% | $84.69K |
| CG oncology Inc | 1.00% | $81.62K |
| BeOne Medicines Ltd | 0.94% | $76.88K |
| Rhythm Pharmaceuticals Inc | 0.94% | $76.64K |
| Glaukos Corp | 0.93% | $75.57K |
| Arrowhead Pharmaceuticals Inc | 0.87% | $70.69K |
| 10X Genomics Inc | 0.87% | $70.56K |
| HeartFlow Inc | 0.86% | $70.23K |
| Encompass Health Corp | 0.83% | $67.70K |
| GeneDx Holdings Corp | 0.81% | $65.78K |
| TransMedics Group Inc | 0.80% | $65.51K |
| DBV Technologies SA | 0.77% | $62.43K |
| Stryker Corp | 0.72% | $58.61K |
| Protagonist Therapeutics Inc | 0.70% | $57.40K |
| Newamsterdam Pharma Co NV | 0.68% | $55.52K |
| Alumis Inc | 0.66% | $53.90K |
| Nuvalent Inc | 0.64% | $52.15K |
| Samsung Biologics Co Ltd | 0.62% | $50.85K |
| Repligen Corp | 0.62% | $50.28K |
| IDEXX Laboratories Inc | 0.61% | $49.91K |
| Roivant Sciences Ltd | 0.51% | $41.40K |
| Oruka Therapeutics Inc | 0.51% | $41.25K |
| Apogee Therapeutics Inc | 0.50% | $40.37K |
| Scholar Rock Holding Corp | 0.47% | $38.31K |
| RadNet Inc | 0.47% | $38.00K |
| ORIC Pharmaceuticals Inc | 0.38% | $30.92K |
| Citibank NA | 0.19% | $15.55K |
| Argenx SE | 0.07% | $5.49K |
LHCCX overview: performance, fees, allocation and SEC filings